Parabilis Medicines announced positive Phase 1/2 data for zolucatetide, showing a 72.2% response rate in desmoid tumor patients and a strong safety profile. The company aligned with the FDA on Phase 3 trial design, aiming to start the PEDESTAL trial in early 2027 with results expected in 2029. They also initiated studies in other diseases and collaborations to explore combination therapies. With $1.1 billion in cash, Parabilis is well-funded to advance its pipeline through 2030.
Parabilis Medicines' recent financial results and business updates provide context for readers following health-sector developments. For readers following health-sector stocks on Pluang as of Nov 12, 2026 18:11 WIB, out of 150 priced US health stocks, 84 rose and 57 fell. Notable movers include TECH (BIO-TECHNE Corp) at USD 71.00 with a 1-day change of -2.47% and 100% buy order activity, HIMS (Hims and Hers Health Inc) at USD 20.32 down 2.35% with 82% sell order activity, and NUWE (Nuwellis Inc) at USD 5.66 up 2.35% with 100% sell order activity.
Tilray Brands announced that its subsidiaries 10 Barrel Brewing, Widmer Brothers Brewing, and Hop Valley Brewing are now the official craft beer partners of the Portland Trail Blazers. This partnership expands the availability of Oregon craft beers a...
Titan Mining reported a 146% increase in nine-month Adjusted EBITDA to $19.8 million, driven by a 38% rise in revenue to $67.9 million. Despite some production delays, zinc output is expected to improve in Q4 2026. The company is progressing its U.S....
Nexpu Ltd.'s subsidiary, Top Kingwin Hi Tech Inc., has finished delivering all 10,000 TK-D2C robots to Walkers Times International under a $4.8 million resale contract signed in 2025. The deliveries were completed in batches, with the final 5,000 uni...
Katapult Holdings announced its third quarter 2026 financial results, reporting total revenues of $753.9 million and an adjusted EBITDA of $110.4 million, reflecting a 23% increase year-over-year on a combined basis. The company completed a merger wi...
A new report from Fiverr reveals that 81% of full-time U.S. employees want to become their own boss, with 42% prioritizing independence over higher pay. This trend, dubbed "The Great Flexit," shows workers quietly preparing to freelance by building A...
